Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 97

1.

Regional differences in milk and complementary feeding patterns in infants participating in an international nutritional type 1 diabetes prevention trial.

Nucci AM, Virtanen SM, Sorkio S, Bärlund S, Cuthbertson D, Uusitalo U, Lawson ML, Salonen M, Berseth CL, Ormisson A, Lehtonen E, Savilahti E, Becker DJ, Dupré J, Krischer JP, Knip M, Åkerblom HK; TRIGR Investigators..

Matern Child Nutr. 2016 Oct 7. doi: 10.1111/mcn.12354. [Epub ahead of print]

PMID:
27714970
2.

Hydrolyzed infant formula and early β-cell autoimmunity: a randomized clinical trial.

Knip M, Åkerblom HK, Becker D, Dosch HM, Dupre J, Fraser W, Howard N, Ilonen J, Krischer JP, Kordonouri O, Lawson ML, Palmer JP, Savilahti E, Vaarala O, Virtanen SM; TRIGR Study Group..

JAMA. 2014 Jun 11;311(22):2279-87. doi: 10.1001/jama.2014.5610.

3.

Recruitment and retention of participants for an international type 1 diabetes prevention trial: a coordinators' perspective.

Franciscus M, Nucci A, Bradley B, Suomalainen H, Greenberg E, Laforte D, Kleemola P, Hyytinen M, Salonen M, Martin MJ, Catte D, Catteau J; TRIGR Investigators..

Clin Trials. 2014 Apr;11(2):150-8. doi: 10.1177/1740774513510070.

4.

Use of vitamin D supplements during infancy in an international feeding trial.

Lehtonen E, Ormisson A, Nucci A, Cuthbertson D, Sorkio S, Hyytinen M, Alahuhta K, Berseth C, Salonen M, Taback S, Franciscus M, González-Frutos T, Korhonen TE, Lawson ML, Becker DJ, Krischer JP, Knip M, Virtanen SM; TRIGR Investigators..

Public Health Nutr. 2014 Apr;17(4):810-22.

5.

Growth differences between North American and European children at risk for type 1 diabetes.

Nucci AM, Becker DJ, Virtanen SM, Cuthbertson D, Softness B, Huot C, Wasikowa R, Dosch HM, Akerblom HK, Knip M; TRIGR Study Group..

Pediatr Diabetes. 2012 Aug;13(5):425-31. doi: 10.1111/j.1399-5448.2011.00840.x.

6.

[History of diabetology in Lower Silesia].

Wąsikowa RB, Basiak A.

Pediatr Endocrinol Diabetes Metab. 2011;17(4):228-32. Polish.

PMID:
22248784
7.

[Primary prevention of type 1 diabetes. Actual situation and perspectives].

Wąsikowa R, Basiak A.

Pediatr Endocrinol Diabetes Metab. 2012;18(4):147-52. Review. Polish.

PMID:
23739619
8.

[Progress in diagnostics and therapy of type 1 and type 2 diabetes--part 2].

Basiak A, Wąsikowa R.

Pediatr Endocrinol Diabetes Metab. 2010;16(3):213-5. Review. Polish.

PMID:
21092702
9.

[Evaluation of the risk of diabetes in the offspring of patients with diagnosis of type 2 diabetes].

Szykowna I, Wasikowa R.

Pediatr Endocrinol Diabetes Metab. 2009;15(2):71-83. Polish.

PMID:
19772814
10.

[Lipoatrophy after use of long acting insulin glargine analogue in a 32-year-old patient with type 1 diabetes].

Dziura M, Wasikowa R.

Pediatr Endocrinol Diabetes Metab. 2008;14(1):61-3. Polish.

PMID:
18577350
11.

Progress in the treatment of diabetes type 1 and 2.

Wasikowa RB, Basiak A.

Pediatr Endocrinol Diabetes Metab. 2007;13(1):47-51. Review.

PMID:
17493407
12.

[Is arterial hypertension a significant problem in children and adolescents with type 1 diabetes?].

Wasikowa R, Basiak A.

Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2006;12(3):229-33. Review. Polish.

PMID:
17020661
13.

[Incidentaloma in a 16 years old girl -- 2 year observation].

Basiak A, Bolanowski M, Wasikowa R, Noczyńska A, Bednorz W.

Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2006;12(2):145-8. Polish.

PMID:
16813722
14.

[Pituitary response to GnRH analogue testing in girls with a polycystic ovary syndrome].

Wikiera B, Wasikowa R.

Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2006;12(1):13-8. Polish.

PMID:
16704856
15.

Chronic autoimmune thyroid disease in children and adolescents in the years 1999-2004 in Lower Silesia, Poland.

Zak T, Noczyńska A, Wasikowa R, Zaleska-Dorobisz U, Golenko A.

Hormones (Athens). 2005 Jan-Mar;4(1):45-8.

16.

[Retrospective comprehensive assessment of the treatment effect of children with growth hormone deficiency].

Kostecka L, Wasikowa R.

Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2005;11(3):161-9. Polish.

PMID:
16232369
17.

Is breast reduction in puberty indicated? Retrospective observations of patients with a local hypersensitivity of estrogen and progesterone receptors.

Noczyńska A, Wasikowa R, Wasik-Kuprianowicz A.

Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2005;11(4):253-5.

PMID:
16232365
18.

[The child from families with type 1 diabetes].

Wasikowa R, Suchańska D, Basiak A, Noczyńska A, Stasińska T.

Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2005;11(4):245-8. Polish. Erratum in: Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2006;12(1):73. Suchańska, Danuta [corrected to Suchańska, Dorota].

PMID:
16232363
19.

Hyperprolactinemia in children during the peripubertal period--personal observations.

Noczyńska A, Wasikowa R.

J Pediatr Endocrinol Metab. 2004 Oct;17(10):1399-404.

PMID:
15526718
20.

[Kallmann's syndrome in families].

Noczyńska A, Wasikowa R.

Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2004;10(2):127-31. Polish.

PMID:
15504317
Items per page

Supplemental Content

Loading ...
Support Center